The most notable studies utilizing MinION in oncohematology have focused on detecting mutations in the TP53 [15] and the ABL1 [16] genes in B-cell chronic lymphocytic leukemia (B-CLL) and CML patients, respectively. Here, ABL1 is linked to B-cell chronic lymphocytic leukemia.